| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 03/29/2011 | US7914804 Slow release pharmaceutical preparation and method of administering same |
| 03/29/2011 | US7914778 Methods of treatment using IL-16 antagonist peptides |
| 03/29/2011 | CA2489276C Tricyclic steroid hormone nuclear receptor modulators |
| 03/29/2011 | CA2470990C 2-indanylamino derivatives for the therapy of chronic pain |
| 03/29/2011 | CA2465326C Pyrazolopyrimidines for decreasing ion flow through a voltage-dependent sodium channel |
| 03/29/2011 | CA2462211C Naphthyridine derivatives, their preparation and their use as phosphodiesterase isoenzyme 4 (pde4) inhibitors |
| 03/29/2011 | CA2447040C Assays, methods and means |
| 03/29/2011 | CA2436980C Amido ether substituted imidazoquinolines |
| 03/29/2011 | CA2434616C (+)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions and uses thereof |
| 03/29/2011 | CA2428223C Compounds and methods for promoting smoking cessation |
| 03/29/2011 | CA2421974C Pulmonary delivery in treating disorders of the central nervous system |
| 03/29/2011 | CA2420562C Creatine ester pronutrient compounds and formulations |
| 03/29/2011 | CA2397016C Use of lipid conjugates in the treatment of disease |
| 03/29/2011 | CA2390652C Human circulating virus-inhibiting peptide (virip) and its use |
| 03/29/2011 | CA2383779C N-(indolecarbonyl)piperazine derivatives |
| 03/29/2011 | CA2299139C 4-phenyl-pyridine derivatives |
| 03/24/2011 | WO2011035314A2 Vitamin d2 enriched mushrooms and fungi for treatment of oxidative stress, alzheimer's disease and associated disease states |
| 03/24/2011 | WO2011035244A2 Tctex-1 regulatory sequence region as stem cell marker |
| 03/24/2011 | WO2011035212A2 Role of n-2 hydroxy-ethyl-piperazine-n'-2-ethane sulfonic acid (hepes) in pain control and reversal of demyelinization injury |
| 03/24/2011 | WO2011035030A2 Induction of neuronal differentiation in non-neuronal cells using a nucleic acid molecule |
| 03/24/2011 | WO2011034920A1 Compositions and methods for treating seizure disorders |
| 03/24/2011 | WO2011034912A1 Compositions and methods for treating spasticity |
| 03/24/2011 | WO2011034887A2 A method for treating neuropathic pain |
| 03/24/2011 | WO2011034832A1 Substituted phenoxymethyl dihydro oxazolopyrimidinones, preparation and use thereof |
| 03/24/2011 | WO2011034830A1 Substituted dihydro benzocycloalkyloxymethyl oxazolopyrimidinones, preparation and use thereof |
| 03/24/2011 | WO2011034828A1 Substituted para-biphenyloxymethyl dihydro oxazolopyrimidinones, preparation and use thereof |
| 03/24/2011 | WO2011034580A2 Small peptide modulators of potassium channel trafficking |
| 03/24/2011 | WO2011034078A1 Glycine compound |
| 03/24/2011 | WO2011034051A1 Novel cyclic squaramide derivatives |
| 03/24/2011 | WO2011033518A1 Sulfanylamide derivatives, uses thereof and compositions comprising them |
| 03/24/2011 | WO2011033358A2 Novel peptides isolated from spider venom, and uses thereof |
| 03/24/2011 | WO2011033305A1 Mannose 6-phosphate for use in promoting peripheral nerve function after injury |
| 03/24/2011 | WO2011033229A1 Acetylene derivatives of 5-phenyl-pyrazolopyridine, preparation thereof, and therapeutic use thereof |
| 03/24/2011 | WO2011033225A2 Substituted 3-amino-cinnolin-4(1h)-one derivatives, preparation thereof, and therapeutic use thereof |
| 03/24/2011 | WO2011033018A1 Substituted n-phenyl-1-(4-pyridinyl)-1h-pyrazol-3-amines |
| 03/24/2011 | WO2011032903A1 Piperazinyl-alkyl-benzoimidazol-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 03/24/2011 | WO2011032416A1 Pharmaceutical composition containing dopamine receptor agonist |
| 03/24/2011 | WO2011032291A1 Selective calcium channel modulators |
| 03/24/2011 | WO2011032233A1 Novel omega conotoxin peptides |
| 03/24/2011 | WO2011032204A1 Treatment of neurological conditions |
| 03/24/2011 | WO2011013128A3 Vectors for delivery of neurotherapeutics to the central nervous system |
| 03/24/2011 | WO2011012140A3 Polymorphs of rasagiline hydrochloride |
| 03/24/2011 | WO2010149363A3 Pharmaceutical composition comprising rotigotine salts (acid or na), especially for iontophoresis |
| 03/24/2011 | WO2010136000A3 Steroide anionic compounds, method of their production, usage and pharmaceutical preparation involving them |
| 03/24/2011 | WO2010120872A3 Method of decreasing pro-adam10 secretase and/or beta secretase levels |
| 03/24/2011 | WO2010117787A3 Inhibiting eph b-3 kinase |
| 03/24/2011 | WO2010111522A3 Mesenchymal stem cells producing inhibitory rna for disease modification |
| 03/24/2011 | WO2010108008A3 Bsc cell differentiation and use in therapy |
| 03/24/2011 | WO2010105093A3 Implantable device for long-term delivery of drugs |
| 03/24/2011 | WO2010087981A3 Bicyclic amide derivatives for enhancing glutamatergic synaptic responses |
| 03/24/2011 | US20110071224 Novel gamma-secretase inhibitor |
| 03/24/2011 | US20110071218 Novel amino acid derivatives, method for preparing same, and therapeutic use thereof |
| 03/24/2011 | US20110071209 RNAi Modulation of the RHO-A Gene and Uses Thereof |
| 03/24/2011 | US20110071207 Oligomer-Aryloxy-Substituted Propanamine Conjugates |
| 03/24/2011 | US20110071206 Modulators of ATP-Binding Cassette Transporters |
| 03/24/2011 | US20110071199 Thiophenyl Sulfonamides for the Treatment of Alzheimer's Disease |
| 03/24/2011 | US20110071197 Bis-aryl compounds for use as medicaments |
| 03/24/2011 | US20110071189 3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof |
| 03/24/2011 | US20110071188 3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof |
| 03/24/2011 | US20110071187 3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof |
| 03/24/2011 | US20110071183 Manufacture of lozenge product with radiofrequency |
| 03/24/2011 | US20110071180 Sub-type selective amides of diazabicycloalkanes |
| 03/24/2011 | US20110071179 Macrocyclic inhibitors of jak |
| 03/24/2011 | US20110071178 Methods and Compounds for Modulating Cannabinoid Activity |
| 03/24/2011 | US20110071168 Nitric oxide donors for inducing neurogenesis |
| 03/24/2011 | US20110071162 Triazolopyridine carboxamide derivatives and triazolopyrimidine carboxamide derivatives, preparation thereof and therapeutic use thereof |
| 03/24/2011 | US20110071161 Triazolopyridine carboxamide derivatives, preparation thereof and therapeutic use thereof |
| 03/24/2011 | US20110071160 1,3-DIHYDRO-2H-PYRROLO[3,2-b]PYRIDIN-2-ONE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USES THEREOF |
| 03/24/2011 | US20110071159 6- (4-cyclopropylpiperazin-1-yl) -2 ' -methyl- [3, 4 ' ] -bipyridine and its use as a medicament |
| 03/24/2011 | US20110071157 Role of N-2-Hydroxy-Ethyl-Piperazine-N'-2-Ethane Sulfonic Acid (HEPES) in Pain Control and Reversal of Demyelinization Injury |
| 03/24/2011 | US20110071156 Heteroaryl-substituted 1,3-dihydroindol-2-one derivatives and medicaments containing them |
| 03/24/2011 | US20110071154 Pyrrolidin-3-ylmethyl-amine as orexin antagonists |
| 03/24/2011 | US20110071152 5-membered heterocycle-based p38 kinase inhibitors |
| 03/24/2011 | US20110071149 Selective kinase inhibitors |
| 03/24/2011 | US20110071140 Therapeutic pyrazoloquinoline urea derivatives |
| 03/24/2011 | US20110071139 Cycloalkyl Lactame Derivatives As Inhibitors Of 11-Beta-Hydroxysteroid Dehydrogenase 1 |
| 03/24/2011 | US20110071135 Method and composition for treating alzheimer-type dementia |
| 03/24/2011 | US20110071132 Substituted oxindole derivatives, drugs containing said derivatives and the use thereof |
| 03/24/2011 | US20110071131 Substituted Spirocyclic Piperidine Derivatives as Histamine-3 (H3) Receptor Ligands |
| 03/24/2011 | US20110071130 2-aminobenzimidazoles for treating neurodegenerative diseases |
| 03/24/2011 | US20110071129 Spirodiamine-diaryl ketoxime derivative |
| 03/24/2011 | US20110071128 Novel imidazopyridines |
| 03/24/2011 | US20110071127 Compounds Which Modulate the CB2 Receptor |
| 03/24/2011 | US20110071126 Inhibitors of beta-secretase |
| 03/24/2011 | US20110071124 Compounds that Inhibit Production of sAPPB and AB and Uses Thereof |
| 03/24/2011 | US20110071113 Thiazole Derivatives and Use Thereof |
| 03/24/2011 | US20110071102 Compositions and Methods to Treat Recurrent Medical Conditions |
| 03/24/2011 | US20110071095 Compositions and Methods for Increasing Telomerase Activity |
| 03/24/2011 | US20110071088 Method for treating neurological disorders |
| 03/24/2011 | US20110071080 Methods and compositions for sleep disorders and other disorders |
| 03/24/2011 | US20110071078 Methods for treating neurological deficits |
| 03/24/2011 | US20110070319 Bifeprunox doses for treating schizophrenia |
| 03/24/2011 | US20110070309 Pharmaceutical formulation comprising a water-insoluble active agent |
| 03/24/2011 | US20110070305 Sustained release pharmaceutical composition containing mebicar |
| 03/24/2011 | US20110070299 Delayed release pharmaceutical composition of duloxetine |
| 03/24/2011 | US20110070298 Compositions Comprising Liposomes, An Antigen, A Polynucleotide and A Carrier Comprising a Continuous Phase of a Hydrophobic Substance |
| 03/24/2011 | US20110070291 Food or beverage composition fortified with thyronamines and/or thyronamine precursors |
| 03/24/2011 | US20110070286 Process for the manufacture of nicotine-comprising chewing gum and nicotine-comprising chewing gum manufactured according to said process |
| 03/24/2011 | US20110070281 Reparative cell delivery via hyaluronic acid vehicles |
| 03/24/2011 | US20110070255 Immunogenic peptide composition for the prevention and treatment of alzheimer's disease |